|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2958945 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14707647.5 |
| Date of filing the European patent application | 2014-02-18 | |
| (97) | Date of publication of the European application | 2015-12-30 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-19 |
| (46) | Date of publication of the claims translation | 2022-11-25 |
| (86) | Number | PCT/EP2014/000433 |
| Date | 2014-02-18 |
| (87) | Number | WO 2014/127906 |
| Date | 2014-08-28 |
| (30) | Number | Date | Country code |
| PCT/EP2013/000505 | 2013-02-20 | WO |
| (72) |
SAHIN,Ugur , DE
TÜRECI, Özlem , DE
MITNACHT-KRAUS, Rita , DE
WÖLL, Stefan , DE
JACOBS, Stefan , DE
HEINZ, Cornelia , DE
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku
Tokyo 103-8411,
JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuota terapija su antikūnais prieš klaudiną 18.2, skirta vėžiui gydyti |
| COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2026-02-02 | 13 | 289.00 EUR |
| 2027-02-18 |